A

AFT Pharmaceuticals Ltd
NZX:AFT

Watchlist Manager
AFT Pharmaceuticals Ltd
NZX:AFT
Watchlist
Price: 2.84 NZD 1.43% Market Closed
Market Cap: 297.8m NZD
Have any thoughts about
AFT Pharmaceuticals Ltd?
Write Note

Income Statement

Earnings Waterfall
AFT Pharmaceuticals Ltd

Revenue
198.5m NZD
Cost of Revenue
-110m NZD
Gross Profit
88.5m NZD
Operating Expenses
-69.4m NZD
Operating Income
19.2m NZD
Other Expenses
-7.6m NZD
Net Income
11.6m NZD

Income Statement
AFT Pharmaceuticals Ltd

Rotate your device to view
Income Statement
Currency: NZD
Mar-2016 Sep-2016 Mar-2017 Sep-2017 Mar-2018 Sep-2018 Mar-2019 Sep-2019 Mar-2020 Sep-2020 Mar-2021 Sep-2021 Mar-2022 Sep-2022 Mar-2023 Sep-2023 Mar-2024 Sep-2024
Revenue
Revenue
64
N/A
64
+0%
69
+8%
76
+10%
81
+7%
83
+2%
85
+2%
94
+10%
106
+12%
107
+2%
113
+5%
120
+6%
130
+9%
141
+8%
157
+11%
175
+11%
195
+12%
199
+2%
Gross Profit
Cost of Revenue
(40)
(40)
(43)
(46)
(46)
(44)
(44)
(50)
(57)
(60)
(64)
(65)
(69)
(77)
(84)
(94)
(107)
(110)
Gross Profit
24
N/A
24
+2%
26
+8%
30
+14%
35
+20%
39
+11%
41
+4%
44
+9%
48
+9%
47
-2%
49
+3%
55
+13%
62
+12%
64
+3%
73
+14%
80
+10%
88
+10%
89
+0%
Operating Income
Operating Expenses
(32)
(37)
(40)
(42)
(44)
(41)
(34)
(34)
(37)
(37)
(38)
(41)
(41)
(45)
(53)
(61)
(64)
(69)
Selling, General & Administrative
(26)
(29)
(32)
(32)
(37)
(38)
(34)
(33)
(35)
(34)
(35)
(37)
(36)
(40)
(47)
(54)
(55)
(60)
Research & Development
0
(10)
(11)
(12)
(8)
(5)
(3)
0
(2)
(4)
(3)
(4)
(6)
(5)
(6)
(6)
(8)
(10)
Depreciation & Amortization
0
0
0
0
(0)
0
(0)
0
(0)
0
(0)
0
(0)
0
(1)
0
(1)
0
Other Operating Expenses
(6)
2
3
3
1
2
2
0
1
0
1
1
0
0
0
0
1
0
Operating Income
(9)
N/A
(13)
-54%
(14)
-8%
(12)
+15%
(9)
+29%
(2)
+73%
7
N/A
10
+57%
12
+11%
10
-14%
11
+8%
14
+29%
20
+48%
18
-10%
20
+7%
19
-1%
24
+25%
19
-21%
Pre-Tax Income
Interest Income Expense
(3)
(1)
(3)
(5)
(6)
(5)
(9)
(10)
(8)
(5)
(3)
(3)
(2)
(3)
(4)
(3)
(2)
(3)
Non-Reccuring Items
0
0
0
0
0
0
0
10
10
(0)
0
0
0
0
0
0
0
0
Total Other Income
(1)
(4)
(1)
3
2
(3)
0
1
(0)
(0)
0
0
(0)
1
0
(1)
0
1
Pre-Tax Income
(13)
N/A
(18)
-35%
(18)
-2%
(14)
+24%
(13)
+9%
(10)
+18%
(2)
+78%
12
N/A
13
+8%
4
-67%
8
+88%
11
+41%
19
+68%
16
-12%
16
-4%
16
-1%
22
+41%
17
-22%
Net Income
Tax Provision
0
0
(0)
(0)
(0)
0
(0)
(0)
(0)
(0)
(0)
(0)
1
1
(5)
(5)
(6)
(6)
Income from Continuing Operations
(13)
(18)
(18)
(14)
(13)
(10)
(2)
12
13
4
8
11
20
17
11
11
16
11
Income to Minority Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Net Income (Common)
(13)
N/A
(18)
-35%
(18)
-3%
(14)
+22%
(14)
+5%
(11)
+20%
(3)
+69%
11
N/A
12
+9%
3
-74%
8
+154%
11
+40%
20
+86%
17
-14%
11
-38%
11
+3%
16
+42%
12
-26%
EPS (Diluted)
-0.14
N/A
-0.18
-29%
-0.19
-6%
-0.15
+21%
-0.14
+7%
-0.11
+21%
-0.03
+73%
0.11
N/A
0.12
+9%
0.03
-75%
0.07
+133%
0.11
+57%
0.19
+73%
0.16
-16%
0.1
-38%
0.11
+10%
0.15
+36%
0.11
-27%

See Also

Discover More